| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 538 | 8.174 | 40.662 | 68.682 | 63.438 |
| Total Income - EUR | - | - | - | - | - | 538 | 8.174 | 40.663 | 68.683 | 63.438 |
| Total Expenses - EUR | - | - | - | - | - | 1.625 | 8.948 | 14.692 | 20.279 | 40.654 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -1.088 | -773 | 25.970 | 48.404 | 22.785 |
| Net Profit/Loss - EUR | - | - | - | - | - | -1.104 | -876 | 25.476 | 47.820 | 20.977 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Nutrilife Science S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 114 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 287 | 3.148 | 24.544 | 88.670 | 108.083 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 295 | 2.088 | 6.332 | 83.759 | 102.587 |
| Cash | - | - | - | - | - | -8 | 1.060 | 18.212 | 4.911 | 5.496 |
| Shareholders Funds | - | - | - | - | - | -1.063 | -1.915 | 23.555 | 71.304 | 91.882 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 1.463 | 5.062 | 989 | 17.366 | 16.201 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Nutrilife Science S.r.l.